General MedicationsORALGeneric
DOXYCYCLINE
DOXYCYCLINE
Standard Dose
EQ 150MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview DOXYCYCLINE is listed in Drugs@FDA under application 202778 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient DOXYCYCLINE Form and strength CAPSULE;ORAL - EQ 150MG BASE Sponsor STRIDES PHARMA Submission history Latest submission status date: 2014-11-26 00:00:00.
Structured Monograph
Clinical summary
Approval overview DOXYCYCLINE is listed in Drugs@FDA under application 202778 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DOXYCYCLINE Form and strength CAPSULE;ORAL - EQ 150MG BASE Sponsor STRIDES PHARMA Submission history Latest submission status date: 2014-11-26 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.